HMGB1 has been shown to be translocated in the cytosol after ischemic stroke and is released extracellularly, which is implicated in the blood–brain barrier (BBB) impairment, neuroimmune activation, and neuronal demise [17]. Here, HMGB1 is linked to ischemic stroke.